Skip to main content

Pharmaceutical News and Articles

Comprehensive and up-to-date drug news for both consumers and healthcare professionals.

FDA Will Begin to Regulate Thousands of Lab Tests

FRIDAY, Sept. 29, 2023 -- Faced with growing reports of inaccurate clinical lab tests, the U.S. Food and Drug Administration on Friday announced that it will...

Want a Healthy Old Age? Get Your Finances in Order Now

FRIDAY, Sept. 29, 2023 -- Planning for your long-term financial future doesn’t just make good economic sense — it could also save your...

Oral NSAIDs, Glucocorticoids Seem Effective for Hand Osteoarthritis

FRIDAY, Sept. 29, 2023 -- Oral nonsteroidal anti-inflammatory drugs (NASIDs) and glucocorticoids seem to be effective for hand osteoarthritis (OA), according...

Adverse Mental Health Symptoms Reported During Contraceptive Pill Pause

FRIDAY, Sept. 29, 2023 -- For women taking combined oral contraceptives (COCs), withdrawal during the pill pause is associated with adverse mental health...

Self-Administered Etripamil Safe, Effective for Paroxysmal Supraventricular Tachycardia

FRIDAY, Sept. 29, 2023 -- Investigational etripamil nasal spray is well tolerated for self-treating recurrent episodes of paroxysmal supraventricular...

Sociodemographic Factors Before MS Diagnosis Tied to Disease Severity

FRIDAY, Sept. 29, 2023 -- Education, income, and marital status prior to multiple sclerosis (MS) onset are associated with future symptom and disability...

Alpha-Tryptase Linked to Prevalence of Anaphylaxis, Food Allergy

FRIDAY, Sept. 29, 2023 -- Alpha-tryptase is associated with increased prevalence of anaphylaxis or severe reaction to food, according to a study published...

COVID Triggered More Cases of Deadly Sepsis During Pandemic Than Thought

FRIDAY, Sept. 29, 2023 -- The life-threatening infection sepsis was more common than once thought among COVID-19 patients early in the pandemic. Massachusetts...

Jimmy Carter 'Happy' in At-Home Hospice Care as 99th Birthday Nears

FRIDAY, Sept. 29, 2023 -- Former President Jimmy Carter turned quite a few heads last week when he made a surprise visit to the Plains Peanut Festival in...

Getting COVID Shot During Pregnancy Helps Protect Newborns, CDC Study Finds

FRIDAY, Sept. 29, 2023 – When pregnant women get a COVID vaccine, it helps protect their newborns from the virus, a new government study shows. "These...

FDA Approves Exxua (gepirone) for the Treatment of Major Depressive Disorder in Adults

HOUSTON, Sept. 28, 2023 /PRNewswire/ -- Fabre-Kramer Pharmaceuticals Inc. (Fabre-Kramer), a biopharmaceutical company committed to developing novel therapies...

FDA Approves Pombiliti (cipaglucosidase alfa-atga) + Opfolda (miglustat) for the Treatment of Late-Onset Pompe Disease

PHILADELPHIA, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that the U.S. Food and Drug Administration (FDA) has...

U.S. FDA Approves Subcutaneous Administration of Takeda's Entyvio (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Ulcerative Colitis

OSAKA, Japan and CAMBRIDGE, Massachusetts, September 27, 2023 – Takeda today announced that the U.S. Food and Drug Administration (FDA) has approved a...

FDA Approves Bosutinib for Pediatric Patients with Chronic Myelogenous Leukemia

September 27, 2023 -- On September 26, 2023, the Food and Drug Administration approved bosutinib (Bosulif, Pfizer) for pediatric patients 1 year of age and...

FDA Approves Ryzumvi (phentolamine) Ophthalmic Solution for the Treatment of Pharmacologically-Induced Mydriasis

FARMINGTON HILLS, Mich., and PITTSBURGH, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical...

FDA Accepts Submission to Add PH-ILD to Yutrepia™ Label

MORRISVILLE, N.C., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Liquidia Corporation (the Company) (NASDAQ: LQDA) announced today that the U.S. Food and Drug...

Takeda Announces FDA Acceptance of NDA Resubmission of TAK-721 (budesonide oral suspension) for the Short-Term Treatment of Eosinophilic Esophagitis (EoE)

OSAKA, Japan and CAMBRIDGE, Massachusetts, September 20, 2023 – Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration...

UCB Provides Update on U.S. Regulatory Review of Bimekizumab

Brussels (Belgium), 19 September 2023 – UCB, a global biopharmaceutical company, today provided an update on the Biologics License Application (BLA) for...

FDA Issues Complete Response Letter for neffy® (epinephrine nasal spray) New Drug Application with Request for Additional Study

Company aligned with FDA in August 2023 on both physician labeling and post-market requirements, which included a repeat-dose study of neffy under...

Orchard Therapeutics Announces Acceptance of Biologics License Application for OTL-200 in MLD and Receives Priority Review

PDUFA date set for March 18, 2024 OTL-200 would be the first and only treatment in the U.S. for early-onset MLD Previously published data demonstrated...

BrainStorm Cell Therapeutics Provides Update on FDA Advisory Committee Meeting to Review NurOwn for the Treatment of ALS

NEW YORK, Sept. 27, 2023 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for...

IDEAYA Biosciences Receives Fast Track Designation for IDE161 in a Second Indication for the Treatment of Pretreated, Advanced or Metastatic HR+, Her2-, BRCA1/2 mutant Breast Cancer

SOUTH SAN FRANCISCO, Calif., Sept. 27, 2023 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the...

NMD Pharma initiates Phase II trial of NMD670 in Spinal Muscular Atrophy

Aarhus, Denmark, 26 September 2023 – NMD Pharma A/S, a clinical-stage biotech company developing first-in-class, small molecule ClC-1 inhibitors directly...

Reviva Announces Last Patient Evaluated in Pivotal Phase 3 RECOVER Trial for Brilaroxazine in Schizophrenia

CUPERTINO, Calif., Sept. 25, 2023. Reviva Pharmaceuticals Holdings, Inc. (“Reviva” or the “Company”), a late-stage pharmaceutical...

Datopotamab Deruxtecan Demonstrated Statistically Significant and Clinically Meaningful Progression-Free Survival Benefit in Patients with HR-Positive, HER2-Low or Negative Breast Cancer in TROPION-Breast01 Phase III Trial

22 September 2023 -- Positive high-level results from the TROPION-Breast01 Phase III trial showed datopotamab deruxtecan (Dato-DXd) demonstrated a...

Browse by news type

Drugs.com Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.

Disclaimer

This library contains syndicated news articles. These articles have not been peer-reviewed by Drugs.com, and therefore we cannot guarantee accuracy to the highest ethical standards. Do further research as needed. Consultation with your physician is essential.